Insider · CIK 0001913350
Cristian Luput
Files at MAIA (MAIA Biotechnology, Inc.). First filing Nov 4, 2024, latest Dec 1, 2025.
Cristian Luput files SEC Form 4 as director at MAIA (MAIA Biotechnology, Inc.). Since Nov 4, 2024, Cristian Luput has reported 3 open-market buys worth $107k and 0 open-market sells worth $0, the latest filed on Dec 1, 2025.
A track record needs three past buys with six months of prices behind them; Cristian Luput has 1, so none is measured yet.
The newest scored trade: bought $42k of MAIA on Nov 26, 2025, filed Dec 1, 2025, scored 52 (moderate). In the last 12 months: 2 buys worth $52k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MAIA: MAIA Biotechnology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | MAIA Biotechnology, Inc. | $42k 38,145 shares | +10% | +22% from low-57% from high | |
| 38Weak | MAIA Biotechnology, Inc. | $9,785 10,000 shares | +3% | +11% from low-61% from high | |
| 40Moderate | MAIA Biotechnology, Inc. | $56k 22,133 shares | +6% | - |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +33,536 | $0.00 | $0 | 33,536 | 11 d ago |
| Mar 31, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +28,556 | $0.00 | $0 | 28,556 | Apr 2, 2026 |
| Dec 31, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Optionsderivative | +25,206 | $0.00 | $0 | 25,206 | Jan 5, 2026 |
| Nov 26, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +20,000 | $1.08 | $22k | 419,483 | Dec 1, 2025 |
| Nov 28, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +18,145 | $1.11 | $20k | 437,628 | Dec 1, 2025 |
| Nov 25, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +10,000 | $0.98 | $9,785 | 399,483 | Nov 28, 2025 |
| Oct 2, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +21,434 | $0.00 | $0 | 21,434 | Oct 6, 2025 |
| Jun 30, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +21,350 | $0.00 | $0 | 21,350 | Jul 2, 2025 |
| Apr 4, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +21,042 | $0.00 | $0 | 21,042 | Apr 8, 2025 |
| Nov 1, 2024 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +22,133 | $2.51 | $56k | 389,483 | Nov 4, 2024 |
| Nov 1, 2024 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Warrantsderivative | +22,133 | $2.26 | $50k | 22,133 | Nov 4, 2024 |
Questions about Cristian Luput
Answered from the filings on this page, as of the latest one.
Is Cristian Luput buying or selling?
In the last 12 months Cristian Luput reported 2 open-market buys worth $52k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $42k of MAIA on Nov 26, 2025. Grants, option exercises and tax withholding are not counted.
How did Cristian Luput's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Cristian Luput has 1.
Where does Cristian Luput file Form 4?
Cristian Luput has filed Form 4 at MAIA (MAIA Biotechnology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.